On April 20, 2024, New York State approved several updates to its consumer protection laws, including enactment of Public Health…

On November 20, 2024, the Office of Inspector General (OIG) released its updated Industry-Specific Compliance Program Guidance (ICPG) for nursing…

The Bayh-Dole Act, 35 U.S.C. §§ 200-212[1], creates a program that, ostensibly, encourages the practical use of inventions…

In Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA, Inc., [2023-1169] (June 25, 2024), the Federal Circuit reversed the dismissal…

In Insulet Corp. v. Eoflow, Co, Ltd., [2024-1137] (June 17, 2024), the Federal Circuit reversed a preliminary injunction against manufacturing…

In a recent landmark decision, the United States District Court for the Northern District of Texas issued an opinion and…

As healthcare regulatory attorneys, we’ve seen firsthand the confusion and challenges that arise when health-related entities fall outside the purview…

In Warner Chappel Music, Inc., v. Sherman Nealy, [22–1078] (May 9, 2024), the Supreme Court finally clarified copyright’s 3-year…

Introduction

We’ve all seen it.  Patent attorneys love making up words.  For example, instead of claiming a pipe, a hose…

The results-effective variable doctrine is a caselaw principle where prior art disclosing the “general conditions of a claim” invokes a…

The USPTO released inventorship guidance on February 12, 2024, for inventions assisted by artificial intelligence (AI). The Federal Circuit previously…

In view of the recent Supreme Court decision in Amgen Inc. et al. v. Sanofi et al., 143 S. Ct.